Expression of the bcl-2 family of genes in the course of keratinocyte differentiation

European Journal of Dermatology

Volumn 9, Issue 3, 1999, Pages 191-196

  Tomková, Hana ^a   Fujimoto, Wataru ^a   Arata, Jiro ^a  

^a OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Apoptosis; Bcl 2 family; Differentiation; Keratinocytes; Retinoic acid

Indexed keywords

PROTEIN BAK; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL X; RETINOID;

ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; CULTURE MEDIUM; EPIDERMIS; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; KERATINOCYTE; MITOCHONDRION; MULTIGENE FAMILY; PROTEIN EXPRESSION;

BCL-2 HOMOLOGOUS ANTAGONIST-KILLER PROTEIN; BCL-2-ASSOCIATED X PROTEIN; BCL-X PROTEIN; BLOTTING, WESTERN; CALCIUM; CELL DIFFERENTIATION; CELLS, CULTURED; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; IMMUNOHISTOCHEMISTRY; KERATINOCYTES; KERATINS; MEMBRANE PROTEINS; MULTIGENE FAMILY; NEOPLASM PROTEINS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; TRETINOIN;

EID: 0032935431     PISSN: 11671122     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. 1. Pan H, Yin C, van Dyke T. Apoptosis and cancer mechanisms. Cancer Surv 1997; 29: 305-27.
2. 2. White E. Life, death, and the pursuit of apoptosis. Genes Dev 1996; 10: 1-15.
3. 3. Reed JC. Mechanisms of bcl-2 family protein function and dysfunction in health and disease. Behring Inst Mitt 1996; 97: 72-100.
4. 4. Zamzami N, Brenner C, Marzo I, et al. Subcellular and submitochondrial mode of action of Bcl-2-like oncoproteins. Oncogene 1998; 16: 2265-82.
5. 5. Schendel SL, Montal M, Reed JC. Bcl-2 family proteins as ion-channels. Cell Death Differ 1998; 5: 372-80.
6. 6. Wang HG, Reed JC. Mechanisms of bcl-2 protein function. Histol Histopathol 1998; 13: 521-30.
7. 7. Reed JC. Cytochrome c: can't live with it - can't live without it. Cell 1997; 91: 559-62.
8. 8. Rao L, White E. Bcl-2 and the ICE family of apoptotic regulators: making a connection. Curr Opin Genet Dev 1997; 7: 52-8.
9. 9. Hohl D, Lichti U, Breitkreutz D, et al. Transcription of the human loricrin gene in vitro is induced by calcium and cell density and suppressed by retinoic acid. J Invest Dermatol 1991; 96: 414-8.
10. 10. Saunders NA, Jetten AM. Control of growth regulatory and differentiation-specific genes in human epidermal keratinocytes by interferon γ. Antagonism by retinoic acid and transforming growth factor β1. J Biol Chem 1994; 269: 2016-22.
11. 11. Nelson WG, Sun TT. The 50-and 58-kdalton keratin classes as molecular markers for stratified squamous epithelia: cell culture studies. J Cell Biol 1983; 97: 244-51.
12. 12. Tomková H, Fujimoto W, Arata J. Expression of the bcl-2 homologue bax in normal human skin, psoriasis vulgaris and non-melanoma skin cancers. Eur J Dermatol 1998; 8: 256-60.
13. 13. Tomková H, Fujimoto W, Arata J. Expression of bcl-2 antagonist bak in inflammatory and neoplastic skin diseases. Br J Dermatol 1997; 137: 703-8.
14. 14. Stellmach V, Leask A, Fuchs E. Retinoid-mediated transcriptional regulation of keratin genes in human epidermal and squamous cell carcinoma cells. Proc Natl Acad Sci USA 1991; 88: 4582-6.
15. 15. Song Y, Yaar M, Gilchrest BA. Evidence that Bax mediates keratinocyte differentiation and apoptosis. J Invest Dermatol 1996; 106: 875 (abstr.).
16. 16. Krajewski S, Krajewska M, Reed JC. Immunohistochemical analysis of in vivo patterns of bak expression, a proapoptotic member of the bcl-2 protein family. Cancer Res 1996; 56: 2844-56.
17. 17. Eckert RL, Crish JF, Robinson NA. The epidermal keratinocyte as a model for the study of gene regulation and cell differentiation. Physiol Rev 1997; 77: 397-424.
18. 18. Sermadiras S, Dumas M, Joly-Berville R, et al. Expression of bcl-2 and bax in cultured normal human keratinocytes and melanocytes: relationship to differentiation and melanogenesis. Br J Dermatol 1997; 137: 883-9.
19. 19. Haake AR, Graf BA, Polakowska RR. Bcl-2 downregulation is not required for keratinocyte terminal differentiation. J Invest Dermatol 1995; 104: 572 (abstr.).
20. 20. Wrone-Smith T, Johnson T, Nelson B, et al. Discordant expression of bcl-x and bcl-2 by keratinocytes in vitro and psoriatic keratinocytes in vivo. Am J Pathol 1995; 146: 1079-88.
21. 21. Harada H, Mitsuyasu T, Seta Y, et al. Overexpression of bcl-2 protein inhibits terminal differentiation of oral keratinocytes in vitro. J Oral Pathol Med 1998; 27: 11-7.
22. 22. LeBrun DP, Warnke RA, Cleary ML. Expression of bcl-2 in fetal tissues suggests a role in morphogenesis. Am J Pathol 1993; 142: 743-53.
23. 23. Hockenbery DM, Zutter M, Hickey W, et al. Bcl-2 is topographically restricted in tissues characterized by apoptotic cell death. Proc Natl Acad Sci USA 1991; 88: 6961-5.
24. 24. Cerroni L, Kerl H. Aberrant bcl-2 protein expression provides a possible mechanism of neoplastic growth in cutaneous basal-cell carcinoma. J Cutan Pathol 1994; 21: 398-403.
25. 25. Pincelli C, Magnoni C, Grassilli E, et al. Autocrine nerve growth factor protects human keratinocytes from apoptosis through its high-affinity receptor (TRK): a role for bcl-2. J Invest Dermatol 1996; 106: 829 (abstr.).
26. 26. Krajewski S, Bodrug S, Krajewska M, et al. Immunohistochemical analysis of mcl-1 protein in human tissues. Differential regulation of mcl-1 and bcl-2 protein production suggests a unique role for mcl-1 in control of programmed cell death in vivo. Am J Pathol 1995; 146: 1309-19.
27. 27. Krajewski S, Krajewska M, Shabaik A, et al. Immunohistochemical analysis of in vivo patterns of bcl-X expression. Cancer Res 1994; 54: 5501-7.
28. 28. Pena JC, Fuchs E, Thompson CB. Bcl-x expression influences keratinocyte cell survival but not terminal differentiation. Cell Growth Differ 1997; 8: 619-29.
29. 29. Ashwell JD. When complex worlds collide: retinoic acid and apoptosis. Cell Death Differ 1998; 5: 1-3.
30. 30. Nagy L, Thomázy VA, Heyman RA, Davies JA. Retinoid-induced apoptosis in normal and neoplastic tissues. Cell Death Differ 1998; 5: 11-9.
31. 31. Rogers MB. Life-and-death decisions influenced by retinoids. Curr Topics Dev Biol 1997; 35: 1-46.
32. 32. Nagy L, Thomázy VA, Chandraratna RAS, et al. Retinoid-regulated expression of bcl-2 and tissue transglutaminase during the differentiation and apoptosis of human myeloid leukemia (HL-60) cells. Leukemia Res 1996; 20: 499-505.
33. 33. Watson RWG, Rotstein OD, Parodo J, et al. Granulocytic differentiation of HL-60 cells results in spontaneous apoptosis mediated by increased caspase expression. FEBS Lett 1997; 412: 603-9.
34. 34. Eck KM, Yuan L, Duffy L, et al. A sequential treatment regimen with melatonin and all-trans retinoic acid induces apoptosis in MCF-7 tumour cells. Br J Cancer 1998; 77: 2129-37.
35. 35. Jetten AM. Retinoids specifically enhance the number of epidermal growth factor receptors. Nature 1980; 284: 626-9.
36. L. Oncogene 1998; 16: 1493-9.